Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Comoros Technology Digest.
Press releases published on August 14, 2025
ARRAY Technologies Completes Acquisition of APA Solar
GlobeNewswire
·
August 14, 2025
ALBUQUERQUE, N.M., Aug. 14, 2025 (GLOBE NEWSWIRE) -- ARRAY Technologies (NASDAQ: ARRY) (“ARRAY” or the “Company”), a leading global provider of solar tracking technology products, software, and services for utility-scale solar energy projects, today …
Plus Therapeutics Reports Second Quarter Financial Results and Recent Business Highlights
GlobeNewswire
·
August 14, 2025
Announced CNSide® CSF assay platform launch timeline Initiated the REYOBIQ dose optimization trial for patients with leptomeningeal metastases HOUSTON, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a …
Microchip Technology to Webcast Annual Meeting of Shareholders
GlobeNewswire
·
August 14, 2025
CHANDLER, Ariz., Aug. 14, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today announced that it will webcast its Annual Meeting of Shareholders …
Duos Technologies Group Reports Second Quarter 2025 Results
GlobeNewswire
·
August 14, 2025
JACKSONVILLE, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Duos Technologies Group, Inc. (“Duos” or the “Company”) (Nasdaq: DUOT), a provider of adaptive, versatile and streamlined Edge Data Center (“EDC”) solutions and operational services for the deployment …
Updated time: HP Inc. to Announce Third Quarter Fiscal 2025 Earnings on Aug 27, 2025
GlobeNewswire
·
August 14, 2025
PALO ALTO, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- HP Inc. (NYSE: HPQ) will present a live audio webcast of a conference call to review financial results for the third fiscal quarter ended July 31, 2025 on Wednesday, Aug 27, 2025 at 4:30 p.m. ET / 1:30 p …
Shuttle Pharma Provides Second Quarter 2025 Corporate Update
GlobeNewswire
·
August 14, 2025
GAITHERSBURG, Md., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer …
Diginex Announces extension of Resulticks MOU
GlobeNewswire
·
August 14, 2025
LONDON, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Diginex Limited (“Diginex” or the “Company”) (NASDAQ: DGNX), a leading provider of Sustainability RegTech solutions, today announced that, by mutual consent, the Company and Resulticks Global Companies Pte. …
Fortress Biotech Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
GlobeNewswire
·
August 14, 2025
Fortress subsidiary Checkpoint Therapeutics acquired by Sun Pharma; Fortress received ~$28 million at closing and is eligible to receive up to an additional $4.8 million under a contingent value right (CVR), plus a 2.5% royalty on future net sales of …
Bolt Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 14, 2025
Next-generation claudin 18.2 ISAC BDC-4182 now in Phase 1 dose-escalation study Cash balance of $48.5 million as of June 30, 2025 anticipated to fund key milestones through mid-2026 REDWOOD CITY, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Bolt …
GT Biopharma Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 14, 2025
GTB-3650 TriKE® Phase 1 trial has successfully completed Cohort 1 and Cohort 2 dosing, treating a total of four patients; following Cohort 2’s formal safety review, it has advanced into Cohort 3 and initiated dosing of the fifth patient in the study; …
Pyxis Oncology Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 14, 2025
– Phase 1 monotherapy expansion study of micvotabart pelidotin (MICVO) for recurrent and metastatic head and neck squamous cell carcinoma (R/M HNSCC) patients progressing well with preliminary data in second half of 2025 and first half of 2026 – Phase 1/ …
CAMP4 Reports Second Quarter 2025 Financial Results and Corporate Highlights
GlobeNewswire
·
August 14, 2025
Presented positive translational data from SYNGAP1-related disorders program showcasing efficacy in a humanized SYNGAP mouse model and increased protein in non-human primates at the 28th American Society of Gene and Cell Therapy (ASGCT) Annual Meeting …
Magnite to Participate in Upcoming Financial Conferences
GlobeNewswire
·
August 14, 2025
NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Magnite (Nasdaq: MGNI), the largest independent sell-side advertising company, today announced that members of its executive team will participate and host investor meetings at the following financial conferences …
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2025
GlobeNewswire
·
August 14, 2025
PORTLAND, Maine, Aug. 14, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the …
Trust Stamp files its 2025 Q2 10-Q and announced continued growth in OL Platform Registrations and a Key Performance Metric
GlobeNewswire
·
August 14, 2025
Atlanta, GA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Trust Stamp (Nasdaq: IDAI) announced that: It filed its Q2 10-Q report for the six months ended 30 June 2025 after the Nasdaq market closed on August 14th, 2025. Net recognised revenue for the three months …
Nasus Pharma Announces Closing of Initial Public Offering
GlobeNewswire
·
August 14, 2025
TEL AVIV, Israel, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products to treat emergency medical conditions …
authID Reports Financial and Operating Results for the Second Quarter 2025; Delivers the Highest Revenue in the Company’s History
GlobeNewswire
·
August 14, 2025
DENVER, Aug. 14, 2025 (GLOBE NEWSWIRE) -- authID® (Nasdaq: AUID) (“authID” or the “Company”), a leading provider of biometric identity verification and authentication solutions, today reported financial and operating results for the second quarter ended …
IO Biotech Reports Second Quarter 2025 Financial Results and Provides Business Highlights
GlobeNewswire
·
August 14, 2025
Announced clinical improvement in progression free survival observed in pivotal Phase 3 Trial of Cylembio® plus KEYTRUDA® (pembrolizumab) for the treatment of first-line advanced melanoma, but statistical significance narrowly missed; company plans to meet …
Banzai Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 14, 2025
Revenue of $3.3 Million for Q2 2025, Representing 205% Growth from Q2 2024 Gross Profit of $2.7 Million for Q2 2025, Representing 267% Growth from Q2 2024; Gross Margin Expanded to 83.0% in Q2 2025 a 1390 BPS Increase Management to Host Second Quarter 2025 …
Intchains Group Limited Reports Second Quarter and First Half 2025 Financial Results
GlobeNewswire
·
August 14, 2025
Reinforces its Leading ETH Treasury Position: Increased ETH holdings to 8,816 as of June 30, 2025, up 26% from March 31, 2025, and 55% from December 31, 2024 Updates on Its Long-Term Dollar-Cost Averaging ETH Treasury Strategy Designed to Boost Overall …